University of Vermont

College of Medicine

Department of Pathology and Laboratory Medicine

Bio for Mark Fung, M.D., Ph.D.
Mark Fung, M.D., Ph.D.

Mark Fung, M.D., Ph.D.

Professor, Department of Pathology & Laboratory Medicine
Director of HLA Lab, Department of Pathology & Laboratory Medicine
Director of Clinical Labs, Department of Pathology & Laboratory Medicine


Contact Information
E-mail: Mark.Fung@uvm.edu
Office Location:
EP1-103

Expertise

Transfusion medicine and HLA

Research Interests

Transfusion safety, regional and national transfusion practices, blood donor motivation, transfusion outcomes, HLA platelet compatibility

Postdoctoral Training

2014 Course in Meta-Leadership in Healthcare – 16 credit hours; Harvard School of Public Health,
         Boston, MA, U.S.A.
2012 Course in Leadership Development for Physicians in Academic Health Centers (Institutional
         Policy and Strategy, Operations Management, Financial Analysis and Control, Organizational
         Issues, Conflict Resolution and Negotiation, Clinical Performance Management) – 55 credit
         hours; Harvard School of Public Health, Boston, MA, U.S.A.
2009-2011 Core and Advanced Business Education Program (Organizational Behavior, Finance,
                  Marketing, Operations, Strategy, Negotiations, Project Management) – 40+ credit hours,
                  University of Vermont Center for Health Care Management, Burlington, VT, U.S.A.
2005-2007 Fellow, Program for Research in Medical Outcomes (PRIMO Fellow), Department of
                  General Internal Medicine, University of Vermont, Burlington, VT, U.S.A.
2002-2003 Clinical Fellow, Transfusion Medicine and Blood Banking, University of Pittsburgh
                  School of Medicine and Institute for Transfusion Medicine, Pittsburgh, PA, U.S.A.
2001-2004 Resident in Pathology and Laboratory Medicine (AP/CP), University of Pittsburgh
                  School of Medicine, Pittsburgh, PA, U.S.A.
1999-2001 Resident in Pathology and Laboratory Medicine (AP/CP), Washington University School
                  of Medicine, Saint Louis, MO, U.S.A.

Education

1999 MD, University of Alabama School of Medicine, Birmingham, AL, (Medical Scientist Training Program)
1997 PhD, Univ. of Alabama at Birmingham, AL (Molecular and Cellular Pathology)
1991 MS, Univ. of Illinois at Urbana-Champaign, Urbana, IL (Microbiology)
1989 BA, Wesleyan University, Middletown, CT (Biology)

Academic Appointments

2015-present Professor, Department of Pathology and Laboratory Medicine, University of Vermont,
                       College of Medicine, Burlington, VT, U.S.A.
2013-present Associate Professor (secondary appointment) and Medical Laboratory Science Medical
                       Director, Department of Medical Laboratory and Radiation Sciences,University of
                       Vermont, College of Nursing and Health Sciences, Burlington, VT, U.S.A.
2010-2015 Associate Professor, Department of Pathology and Laboratory Medicine, University of
                  Vermont, College of Medicine, Burlington, VT, U.S.A.
2004-2010 Assistant Professor, Department of Pathology and Laboratory Medicine, University of
                  Vermont, College of Medicine, Burlington, VT, U.S.A.

Awards and Honors

2015 Master Teacher, University of Vermont College of Medicine Teaching Academy
2015 Nominee, Silver Stethoscope medical student teaching award, UVM
2013 Being One Award, University of Vermont Medical Center
2012 Faces of Fletcher Allen, University of Vermont Medical Center
2009 Good Catch Award, University of Vermont Medical Center
2003 Foundation Scholar, College of American Pathologists (CAP)

Publications

Jones, C.A., Ducis, K., Petrozzino, J., Clark, E., Fung, M.K., Peters, C., Sarkar, I.N., Krol, E., Pochal, B., Boutrus, A., Weimersheimer, P., Freeman, K. 2015. Prevention of treatment-related fluid overload reduces estimated effective cost of prothrombin complex concentrate in patients requiring rapid vitamin K antagonist reversal. Expert Review of Pharmacoeconomics & Outcomes Research (in press).

Vossoughi, S.R.*, Macauley, R., Sazama, K., Fung, M.K. 2015Attitudes, practices, and training on informed consent:a survey of medical students and physicians.Am J of Clinical Pathology 144:315-321 (PMID: 26185317)

AuBuchon, J.P., Fung, M., Whitaker, B., Malasky, J.2014. AABB Validation Study of the CDC National Healthcare Safety Network’s Hemovigilance Module Adverse Events Definitions Protocol.Transfusion 54: 2077-2083. (PMID: 24673261)

Hill, A.M., Stewart, P.W., Fung, M.K., Kris-Etherton, P.M., Ginsberg, H.N., Tracy, R.P., Pearson, T.A., Lefevre, M., Reed, R.G., Elmer, P.J., Holleran, S., Ershow, A.G.; The DELTA (Dietary Effects on Lipoproteins-Thrombogenic Activity) Investigators. 2014.Monthly hemostatic factor variability in women and men.Eur J Clin Invest 44:309-318. (PMID: 24382103)

Lozano, M., Mahon, A., van der Meer, P.F., Stanworth, S., Cid, J., Devine, D.,Fung, M.K., de la Salle, B., Heddle, N.M. 2014. Counting platelets at transfusion threshold levels: impact on the decision to transfuse.A BEST Collaborative-UK NEQAS(H) international exercise. Vox Sanguinis 106: 330-336.

For a complete list of Mark Fung's publications, please visit PubMed.